Skip to main content
Shilpa Medicare Ltd. logo

Shilpa Medicare Ltd. — Investor Relations & Filings

Ticker · SHILPAMED ISIN · INE790G01031 LEI · 3358002PKUL8S2RNJO60 BSE.NS Manufacturing
Filings indexed 817 across all filing types
Latest filing 2025-10-06 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS SHILPAMED

About Shilpa Medicare Ltd.

https://vbshilpa.com/

Shilpa Medicare Ltd. is a research-led organization specializing in the development, manufacture, and commercialization of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a significant focus on the oncology segment, producing a wide range of high-potency anti-cancer drugs. Its capabilities extend to diverse therapeutic areas, including ophthalmology, dermatology, and biosimilars. Shilpa Medicare operates manufacturing facilities compliant with international regulatory standards such as the USFDA and EU-GMP. The organization emphasizes complex chemistry and advanced drug delivery systems, offering a portfolio that includes oral solids, injectables, and transdermal patches. Through its R&D infrastructure, the company provides contract research and manufacturing services to global partners, supporting the lifecycle of generic and innovative pharmaceutical products.

Recent filings

Filing Released Lang Actions
General Updates
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter addressed to stock exchanges notifying them about the allotment of bonus equity shares by the company. It references Regulation 30 of SEBI LODR Regulations, which pertains to disclosure obligations for listed companies. The content details the bonus share issue ratio, record date, and the resulting change in paid-up share capital. There are no financial statements or detailed financial analysis present, and the document is relatively short (2381 characters). This is a clear announcement of a capital change event (bonus share allotment), not a full report or financial statement. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2025-10-06 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication from Shilpa Medicare Limited to stock exchanges regarding the receipt of in-principle approval for a bonus issue of shares. It references regulatory compliance under SEBI (LODR) Regulations, 2015, and details the approval for issuing bonus shares. The document is an announcement of a capital event (bonus shares issuance) and not a full financial report or detailed presentation. It is not a full Annual Report, Interim Report, or Earnings Release. The content fits the category of Capital/Financing Update as it informs about the company's capital structure change (bonus shares). The document length is 4712 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-09-29 English
General Updates
Regulatory Filings Classification · 92% confidence The document is an official stock exchange intimation under SEBI LODR Regulation 31A regarding the reclassification of two shareholders from the “Promoter group” category to the “Public” category. It describes a change in shareholder category and enclosure of an approval letter, but contains no financial statements, no dividend or meeting results, and is not a formal report, so it does not belong to any specific financial report category. It is a routine compliance announcement to the exchanges; thus it should be classified as a general Regulatory Filing (RNS).
2025-09-27 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the receipt of in-principle approval for a bonus issue of shares. It references regulatory compliance under SEBI (LODR) Regulations and provides details about the bonus share ratio and record date. The document is short (2119 characters) and serves as an announcement of approval rather than the actual issuance or detailed report of the bonus shares. This fits the category of a capital/financing update, as it informs about a capital structure change (bonus shares). Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-09-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Shilpa Medicare Limited to stock exchanges regarding the approval of reclassification of certain shareholders from the 'Promoter Group' category to the 'Public' category under Regulation 31A of SEBI (LODR) Regulations, 2015. It includes details of the shareholders, shareholding percentages, and references to regulatory compliance. The document is an announcement of a regulatory approval related to shareholding classification, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-09-26 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Shilpa Medicare Limited addressed to stock exchanges, notifying the closure of the trading window for insiders ahead of the announcement of un-audited financial results for the quarter and half year ended September 30, 2025. It references the upcoming financial results but does not contain any financial data or the results themselves. The document is short (1897 characters) and serves as an announcement related to compliance with insider trading regulations rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2025-09-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.